wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38084363-E450FF80-4F38-41B0-A3A7-CB493D27D638
Q38084363-E450FF80-4F38-41B0-A3A7-CB493D27D638
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38084363-E450FF80-4F38-41B0-A3A7-CB493D27D638
SGLT2 inhibition: a novel prospective strategy in treatment of diabetes mellitus.
P2860
Q38084363-E450FF80-4F38-41B0-A3A7-CB493D27D638
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38084363-E450FF80-4F38-41B0-A3A7-CB493D27D638
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7f9ca0c07505b7cae50b499fdd5842ca57b993f4
P2860
Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus.